RELEASE OF CHOLESTEROL FROM ACTIVATED PLATELETS
从活化的血小板中释放胆固醇
基本信息
- 批准号:3966657
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:
项目摘要
Cholesterol accumulation by cells in the blood vessel wall or in thrombi
associated with blood vessels is the hallmark of the atherosclerotic
lesion. Previous work in our laboratory has shown that platelets can
medicate cholesterol accumulation in vascular smooth muscle cells. This
study shows that when platelets are activated, they release cholesterol.
Washed human or rat platelets, activated with the potent platelet agonist
thrombin, released 50 nmoles of cholesterol per 3 billion platelets. This
amount represents approximately 20 percent of the platelet cholesterol
content. The calcium ionophore, A23187 (5 Mum) was as effective as
thrombin in stimulating cholesterol release, whereas, collagen (200 Mug/ml,
type I) was somewhat less effective. ADP (200 Mum), a less potent platelet
agonist, was ineffective in stimulating cholesterol release.
The release of cholesterol from activated platelets was relatively slow
(less than 90% released within 2 hours) when compared with the rapid
release of serotonin (less than 90% released within 5 min) a constituent of
dense granules. Release of cholesterol was inhibited by the platelet
antagonist forskolin, an agent that elevates platelet cAMP. Release of
cholesterol could be dissociated from release of a cytoplasmic marker
lactate dehydrogenase suggesting that cholesterol release did not result
simply from platelet lysis.
These findings suggest that platelets, in addition to their known function
of stimulating proliferation of cells, are also a source of cholesterol
that may accumulate in cells. Both of these platelet functions are
relevant to the pathogenesis of atherosclerosis, a disease in which cell
proliferation and cellular accumulation of cholesterol are characteristic.
胆固醇在血管壁或血栓中的细胞积聚
是动脉粥样硬化的标志
损伤。 我们实验室之前的工作表明,血小板可以
胆固醇在血管平滑肌细胞中积聚。 这
研究表明,当血小板被激活时,它们会释放胆固醇。
洗涤过的人或大鼠血小板,用强效血小板激动剂活化
凝血酶,每30亿血小板释放50纳摩尔胆固醇。 这
约占血小板胆固醇的20%
内容 钙离子载体A23187(5 μ m)与
凝血酶刺激胆固醇释放,而胶原蛋白(200 μ g/ml,
I型)的效果稍差。 ADP(200 μ m),效力较低的血小板
激动剂,在刺激胆固醇释放方面无效。
活化血小板释放胆固醇相对缓慢
(less 90%以上在2小时内释放),
5-羟色胺的释放(5分钟内释放不到90%),
致密颗粒 血小板抑制胆固醇的释放
拮抗剂毛喉素,一种提高血小板cAMP的药物。 释放
胆固醇可以从细胞质标记物的释放中分离出来,
乳酸脱氢酶表明胆固醇释放没有导致
仅仅是血小板溶解。
这些发现表明,血小板,除了其已知的功能,
也是胆固醇的来源
可能会在细胞中积累。 这两种血小板功能都是
与动脉粥样硬化的发病机制有关,动脉粥样硬化是一种细胞
胆固醇的增殖和细胞积累是特征。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
H S KRUTH其他文献
H S KRUTH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('H S KRUTH', 18)}}的其他基金
PLATELET-MEDIATED CHOLESTEROL ACCUMULATION WITHIN VASCULAR-ASSOCIATED CELLS
血管相关细胞内血小板介导的胆固醇积累
- 批准号:
4694613 - 财政年份:
- 资助金额:
-- - 项目类别:
RELATIONSHIP OF CHOLESTEROL AND CALCIUM DEPOSITION IN ATHEROSCLEROSIS
动脉粥样硬化中胆固醇与钙沉积的关系
- 批准号:
3858066 - 财政年份:
- 资助金额:
-- - 项目类别:
ISOLATION AND CHARACTERIZATION OF LIPID-RICH PARTICLES IN ATHEROSCLEROTIC LESIONS
动脉粥样硬化病变中富含脂质颗粒的分离和表征
- 批准号:
4694612 - 财政年份:
- 资助金额:
-- - 项目类别:
相似国自然基金
PDLIM3-Cholesterol-SMO轴调控SHH通路激活及其在髓母细胞瘤中的功能研究
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
以促内涵体逃逸聚合物PEG-P[Asp(TEP)]-cholesterol为载体构建双级脑靶向基因传递系统沉默BACE1基因的研究
- 批准号:81302714
- 批准年份:2013
- 资助金额:23.0 万元
- 项目类别:青年科学基金项目
相似海外基金
Reducing the production of toxic Abeta peptides in Alzheimer's disease by mutating the APP cholesterol-binding site: a new therapeutic strategy?
通过突变 APP 胆固醇结合位点来减少阿尔茨海默病中有毒 Abeta 肽的产生:一种新的治疗策略?
- 批准号:
MR/Y013859/1 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Research Grant
The role of cholesterol biosynthesis in CAF for tumorigenesis
CAF 中胆固醇生物合成对肿瘤发生的作用
- 批准号:
23K14585 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for Early-Career Scientists
Application of New Tools for Probing the Roles of Sphingolipids and Cholesterol in Influenza Virus Infection
应用新工具探索鞘脂和胆固醇在流感病毒感染中的作用
- 批准号:
10678459 - 财政年份:2023
- 资助金额:
-- - 项目类别:
A novel role of cholesterol and SR-BI in adipocyte biology
胆固醇和 SR-BI 在脂肪细胞生物学中的新作用
- 批准号:
10733720 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Cholesterol-lowering drugs for treatment of pancreatitis: validation of a clinically significant novel therapeutic target and approach
用于治疗胰腺炎的降胆固醇药物:验证具有临床意义的新型治疗靶点和方法
- 批准号:
10585773 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Disturbed Crosstalk between Cholesterol Homeostasis and Inflammation Resolution in NASH
NASH 中胆固醇稳态与炎症消退之间的干扰串扰
- 批准号:
10568478 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Understanding of cholesterol transporter mechanisms via HS-AFM and computational modeling
通过 HS-AFM 和计算模型了解胆固醇转运机制
- 批准号:
22KF0153 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Grant-in-Aid for JSPS Fellows
Healthy Heart Remnant Cholesterol Tackles Diabetes in Youth
健康的心脏残余胆固醇可治疗青少年糖尿病
- 批准号:
499350 - 财政年份:2023
- 资助金额:
-- - 项目类别:
Salary Programs
Intensive cholesterol-lowering intervention and anti-tumor immunity modeled in prostate cancer
以前列腺癌为模型的强化降胆固醇干预和抗肿瘤免疫
- 批准号:
10802975 - 财政年份:2023
- 资助金额:
-- - 项目类别:














{{item.name}}会员




